UK markets closed

TherapeuticsMD, Inc. (TXMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.22-0.13 (-2.05%)
At close: 04:00PM EDT
6.15 -0.07 (-1.13%)
After hours: 06:49PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close6.35
Open6.20
Bid6.15 x 1200
Ask7.10 x 900
Day's range6.11 - 6.39
52-week range1.99 - 41.00
Volume85,091
Avg. volume583,790
Market cap58.623M
Beta (5Y monthly)1.43
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers

    BOCA RATON, Fla., September 12, 2022--TherapeuticsMD, Inc. (NASDAQ: TXMD), ("TherapeuticsMD" or the "Company") an innovative, leading women’s healthcare company, announced today the appointment of Dr. Brian Bernick and Mr. Mark Glickman as the Company’s Interim Co-Chief Executive Officers and Co-Principal Executive Officers. Dr. Bernick and Mr. Glickman succeed Mr. Hugh O’Dowd as the Company’s Chief Executive Officer.

  • Business Wire

    TherapeuticsMD Announces Second Quarter 2022 Financial Results

    BOCA RATON, Fla., August 15, 2022--TherapeuticsMD, Inc. ("TXMD" or the "Company") (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today reported financial results for the Second Quarter ended June 30, 2022.

  • Business Wire

    TherapeuticsMD to Report Second Quarter 2022 Financial Results on August 15, 2022

    BOCA RATON, Fla., August 08, 2022--TherapeuticsMD, Inc. ("TXMD" or the "Company") (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today announced that it will report its second quarter 2022 financial results on Monday, August 15, 2022, at 8:30 a.m. ET prior the opening of the U.S. financial markets.